Protective effects of caffeic acid and caffeic acid phenethyl ester against acrolein-induced neurotoxicity in HT22 mouse hippocampal cells

Neuroscience Letters

Volumn 535, Issue 1, 2013, Pages 146-151

  Huang, Yingjuan ^a   Jin, Minghua ^a   Pi, Rongbiao ^a   Zhang, Junjie ^a   Chen, Meihui ^a   Ouyang, Ying ^b   Liu, Anmin ^b   Chao, Xiaojuan ^a   Liu, Peiqing ^a   Liu, Jun ^b   Ramassamy, Charles ^c   Qin, Jian ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^c INRS INSTITUT ARMAND FRAPPIER   (Canada)

Author keywords

Acrolein; Alzheimer's disease; Caffeic acid; Oxidative stress

Indexed keywords

ACROLEIN; ALPHA SECRETASE; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; CAFFEIC ACID; CAFFEIC ACID PHENETHYL ESTER; GLUTATHIONE; MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DAMAGE; CELL VIABILITY; ENZYME ACTIVATION; HIPPOCAMPUS; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; WESTERN BLOTTING;

ACROLEIN; ADAM PROTEINS; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ANTIOXIDANTS; ASPARTIC ACID ENDOPEPTIDASES; CAFFEIC ACIDS; CELL LINE; CELL SURVIVAL; GLUTATHIONE; GLYCOGEN SYNTHASE KINASE 3; HIPPOCAMPUS; MAP KINASE SIGNALING SYSTEM; MEMBRANE PROTEINS; MICE; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PHENYLETHYL ALCOHOL; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES;

EID: 84873278212     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.12.051     Document Type: Article

References (32)

1. Adibhatla R.M., Hatcher J.F. Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities. Antioxidants and Redox Signalling 2010, 12:125-169.
2. Bradley M.A., Markesbery W.R., Lovell M.A. Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease. Free Radical Biology and Medicine 2010, 48:1570-1576.
3. Choi J.H., Hwang Y.P., Han E.H., Kim H.G., Park B.H., Lee H.S., Park B.K., Lee Y.C., Chung Y.C., Jeong H.G. Inhibition of acrolein-stimulated MUC5AC expression by Platycodon grandiflorum root-derived saponin in A549 cells. Food and Chemical Toxicology 2011, 49:2157-2166.
4. Dodson S.E., Gearing M., Lippa C.F., Montine T.J., Levey A.I., Lah J.J. LR11/SorLA expression is reduced in sporadic Alzheimer disease but not in familial Alzheimer disease. Journal of Neuropathology and Experimental Neurology 2006, 65:866-872.
5. Eom T.K., Ryu B., Lee J.K., Byun H.G., Park S.J., Kim S.K. Beta-secretase inhibitory activity of phenolic acid conjugated chitooligosaccharides. Journal of Enzyme Inhibition and Medicinal Chemistry 2013, 28:214-217.
6. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biology and Medicine 1991, 11:81-128.
7. Fukui M., Choi H.J., Zhu B.T. Mechanism for the protective effect of resveratrol against oxidative stress-induced neuronal death. Free Radical Biology and Medicine 2010, 49:800-813.
8. Hamann K., Nehrt G., Ouyang H., Duerstock B., Shi R. Hydralazine inhibits compression and acrolein-mediated injuries in ex vivo spinal cord. Journal of Neurochemistry 2008, 104:708-718.
9. Jia Z., Misra B.R., Zhu H., Li Y., Misra H.P. Upregulation of cellular glutathione by 3H-1,2-dithiole-3-thione as a possible treatment strategy for protecting against acrolein-induced neurocytotoxicity. Neurotoxicology 2009, 30:1-9.
10. Kawaguchi-Niida M., Shibata N., Morikawa S., Uchida K., Yamamoto T., Sawada T., Kobayashi M. Crotonaldehyde accumulates in glial cells of Alzheimer's disease brain. Acta Neuropathologica 2006, 111:422-429.
11. Kuhla B., Haase C., Flach K., Luth H.J., Arendt T., Munch G. Effect of pseudophosphorylation and cross-linking by lipid peroxidation and advanced glycation end product precursors on tau aggregation and filament formation. Journal of Biological Chemistry 2007, 282:6984-6991.
12. Lee Y., Shin D.H., Kim J.H., Hong S., Choi D., Kim Y.J., Kwak M.K., Jung Y. Caffeic acid phenethyl ester-mediated Nrf2 activation and IkappaB kinase inhibition are involved in NFkappaB inhibitory effect: structural analysis for NFkappaB inhibition. European Journal of Pharmacology 2010, 643:21-28.
13. Liu J., Li L., Suo W.Z. HT22 hippocampal neuronal cell line possesses functional cholinergic properties. Life Sciences 2009, 84:267-271.
14. Lovell M.A., Xie C., Markesbery W.R. Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiology of Aging 2001, 22:187-194.
15. Muneeb U.R., Sultana S. Attenuation of oxidative stress, inflammation and early markers of tumor promotion by caffeic acid in Fe-NTA exposed kidneys of Wistar rats. Molecular and Cellular Biochemistry 2011, 357:115-124.
16. Nam D.T., Arseneault M., Ramassamy C. Regulation of redox-sensitive signaling pathways in rat primary astrocytes following acrolein exposure. Journal of Alzheimer's Disease 2011, 25:263-277.
17. Nam D.T., Arseneault M., Zarkovic N., Waeg G., Ramassamy C. Molecular regulations induced by acrolein in neuroblastoma SK-N-SH cells: relevance to Alzheimer's disease. Journal of Alzheimer's Disease 2010, 21:1197-1216.
18. Nijmeh J., Moldobaeva A., Wagner E.M. Role of ROS in ischemia-induced lung angiogenesis. American Journal of Physiology. Lung Cellular and Molecular Physiology 2010, 299:L535-L541.
19. Roos T.U., Heiss E.H., Schwaiberger A.V., Schachner D., Sroka I.M., Oberan T., Vollmar A.M., Dirsch V.M. Caffeic acid phenethyl ester inhibits PDGF-induced proliferation of vascular smooth muscle cells via activation of p38 MAPK, HIF-1alpha, and heme oxygenase-1. Journal of Natural Products 2011, 74:352-356.
20. Satoh K., Yamada S., Koike Y., Igarashi Y., Toyokuni S., Kumano T., Takahata T., Hayakari M., Tsuchida S., Uchida K. A 1-hour enzyme-linked immunosorbent assay for quantitation of acrolein- and hydroxynonenal-modified proteins by epitope-bound casein matrix method. Analytical Biochemistry 1999, 270:323-328.
21. Scapagnini G., Sonya V., Nader A.G., Calogero C., Zella D., Fabio G. Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders. Molecular Neurobiology 2011, 44:192-201.
22. Scapagnini G., Foresti R., Calabrese V., Giuffrida Stella A.M., Green C.J., Motterlini R. Caffeic acid phenethyl ester and curcumin: a novel class of heme oxygenase-1 inducers. Molecular Pharmacology 2002, 61:554-561.
23. Seidler N.W., Squire T.J. Abeta-polyacrolein aggregates: novel mechanism of plastic formation in senile plaques. Biochemical and Biophysical Research Communications 2005, 335:501-504.
24. Srivastava S., Sithu S.D., Vladykovskaya E., Haberzettl P., Hoetker D.J., Siddiqui M.A., Conklin D.J., D'Souza S.E., Bhatnagar A. Oral exposure to acrolein exacerbates atherosclerosis in apoE-null mice. Atherosclerosis 2011, 215:301-308.
25. Sul D., Kim H.S., Lee D., Joo S.S., Hwang K.W., Park S.Y. Protective effect of caffeic acid against beta-amyloid-induced neurotoxicity by the inhibition of calcium influx and tau phosphorylation. Life Sciences 2009, 84:257-262.
26. Sultana R., Butterfield D.A. Role of oxidative stress in the progression of Alzheimer's disease. Journal of Alzheimer's Disease 2010, 19:341-353.
27. Tanel A., Averill-Bates D.A. P38 and ERK mitogen-activated protein kinases mediate acrolein-induced apoptosis in Chinese hamster ovary cells. Cellular Signalling 2007, 19:968-977.
28. Teismann P., Sathe K., Bierhaus A., Leng L., Martin H.L., Bucala R., Weigle B., Nawroth P.P., Schulz J.B. Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity. Neurobiology of Aging 2012, 33:2478-2490.
29. Tomitori H., Nakamura M., Sakamoto A., Terui Y., Yoshida M., Igarashi K., Kashiwagi K. Augmented glutathione synthesis decreases acrolein toxicity. Biochemical and Biophysical Research Communications 2012, 418:110-115.
30. Wang H.T., Hu Y., Tong D., Huang J., Gu L., Wu X.R., Chung F.L., Li G.M., Tang M.S. Effect of carcinogenic acrolein on DNA repair and mutagenic susceptibility. Journal of Biological Chemistry 2012, 287:12379-12386.
31. Waragai M., Yoshida M., Mizoi M., Saiki R., Kashiwagi K., Takagi K., Arai H., Tashiro J., Hashimoto M., Iwai N., Uemura K., Igarashi K. Increased protein-conjugated acrolein and amyloid-beta40/42 ratio in plasma of patients with mild cognitive impairment and Alzheimer's disease. Journal of Alzheimer's Disease 2012, 32:33-41.
32. Williams T.I., Lynn B.C., Markesbery W.R., Lovell M.A. Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in mild cognitive impairment and early Alzheimer's disease,. Neurobiology of Aging 2006, 27:1094-1099.